Claudio Jommi

Professor of Practice

Bocconi University

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Claudio Jommi is a Professor of Practice at Università Bocconi in Italy. His research areas include health technology assessment, market access for pharmaceuticals, and the economic evaluation of healthcare interventions, with recent publications focusing on obesity, financial toxicity in cancer patients, and innovative therapy negotiations. He aims to enhance the understanding of healthcare consumption and quality of life in the context of rare diseases and healthcare systems.

Articles (12)

Year:

2025

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Silvia Riva

Associate Professor

St Mary's University

UNITED KINGDOM

View details

PATRIZIO ARMENI

Associate Professor of Practice

SDA Bocconi School of Management

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Claudio Jommi

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past?

Obesity in Italy: An Empirical Analysis of Healthcare Consumption, Quality of Life and Comorbidities

An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration

Erratum: Facilitating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework (International Journal of Technology Assessment in Health Care (2022) 38:1 (E23) DOI: 10.1017/S0266462322000095)

Faciliating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework

Unmet clinical need and new therapeutic options,Unmet clinical need e nuovi farmaci

Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system.

A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system

Key drivers of innovativeness appraisal for medicines: The Italian experience after the adoption of the new ranking system

Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach?

Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?

Collaborators (2)

Silvia Riva

PATRIZIO ARMENI

Make your next move.